ECOG performance status is an important risk factor for early mortality in metastatic castration-resistant prostate cancer (mCRPC). Patients with metastatic castration-resistant prostate cancer (mCRPC ...
An examination of translated content on NCI-designated cancer websites with a focus on breast and colorectal cancer. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback